肺高血圧症患者を対象としたモバイルアプリを用いたマインドフルネスに基づくセルフマネジメントプログラム:単群実現可能性調査
Yuka Takita1, Junko Morishita2, Sunre Park3
1Department of Nursing, Faculty of Medical Technology, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan, 81 3 3964 1211 ext 46114, 81 3 3964 3365.
JMIR cardio
|February 4, 2026
まとめ
PH患者向けの新しいオンラインマインドフルネスプログラムは、生活の質と回復力を向上させました。このセルフマネジメント介入は、PHの症状や感情の管理に有望です。
科学分野:
- 肺高血圧症研究
- マインドフルネス介入
- デジタルヘルス
背景:
- マインドフルネスに基づく介入は慢性疾患に使用されていますが、肺高血圧症(PH)に合わせたプログラムが不足していました。
- PH患者の移動性の制限は、アクセス可能で遠隔の介入を必要とします。
主な方法:
- PHセルフマネジメント教育とマインドフルネスに基づく認知療法を組み合わせた、週1回の8セッションのオンラインプログラム。
- 症状モニタリングとマインドフルネスの実践のためにモバイルアプリとApple Watchを使用しました。
- 生活の質(emPHasis-10)、抑うつ(PHQ-9)、不安(GAD-7)、回復力(CD-RISC)、孤独感をベースライン、4週目、プログラム完了時に評価しました。
結論:
- オンラインマインドフルネスプログラムは、PH患者の症状と感情の管理に有益であると思われます。
- この介入は、肺高血圧症患者の生活の質を向上させる可能性を示しています。
- これらの予備的な発見を確認するために、ランダム化比較試験でのさらなる評価が推奨されます。
関連する概念動画
Hypertension V: Nursing Management
445
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
445
Pulmonary Hypertension: Classification and Pathogenesis
659
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
659
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
613
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
613
Pulmonary Embolism III: Nursing Management
447
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
447
Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
471
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
471


